SARS‐CoV‐2, periodontal pathogens, and host factors: The trinity of oral post‐acute sequelae of COVID‐19
Reviews in Medical Virology · 2024
DOI: 10.1002/rmv.2543 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2024. Verfasst von Joel Schwartz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine and Diagnostic Sciences, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Periodontal Diseases, Post-Acute COVID-19 Syndrome, SARS-CoV-2. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIDCR/National Institutes of Health, NEI NIH HHS.
Abstract (Originalsprache)
COVID‐19 as a pan‐epidemic is waning but there it is imperative to understand virus interaction with oral tissues and oral inflammatory diseases. We review periodontal disease (PD), a common inflammatory oral disease, as a driver of COVID‐19 and oral post‐acute‐sequelae conditions (PASC). Oral PASC identifies with PD, loss of teeth, dysgeusia, xerostomia, sialolitis‐sialolith, and mucositis. We contend that PD‐associated oral microbial dysbiosis involving higher burden of periodontopathic bacteria provide an optimal microenvironment for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These pathogens interact with oral epithelial cells activate molecular or biochemical pathways that promote viral adherence, entry, and persistence in the oral cavity. A repertoire of diverse molecules identifies this relationship including lipids, carbohydrates and enzymes. The S protein of SARS‐CoV‐2 binds to the ACE2 receptor and is activated by protease activity of host furin or TRMPSS2 that cleave S protein subunits to promote viral entry. However, PD pathogens provide additional enzymatic assistance mimicking furin and augment SARS‐CoV‐2 adherence by inducing viral entry receptors ACE2/TRMPSS, which are poorly expressed on oral epithelial cells. We discuss the mechanisms involving periodontopathogens and host factors that facilitate SARS‐CoV‐2 infection and immune resistance resulting in incomplete clearance and risk for ‘long‐haul’ oral health issues characterising PASC. Finally, we suggest potential diagnostic markers and treatment avenues to mitigate oral PASC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Medicine and Diagnostic Sciences, University of Illinois Chicago, Chicago, Illinois, USA.
- Department of Periodontics, University of Illinois Chicago, Chicago, Illinois, USA.
- Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois, USA.
ORCID-Profile: Afsar R Naqvi
Förderung
- NIDCR NIH HHS
- NIDCR/National Institutes of Health
- NEI NIH HHS
- NEI/NIH
- National Institutes of Health
Zitieren
APA
Schwartz, J., Capistrano, K. J., Gluck, J., Hezarkhani, A., & Naqvi, A. R. (2024). SARS‐CoV‐2, periodontal pathogens, and host factors: The trinity of oral post‐acute sequelae of COVID‐19. Reviews in Medical Virology. https://doi.org/10.1002/rmv.2543
Vancouver
Schwartz J, Capistrano KJ, Gluck J, Hezarkhani A, Naqvi AR. SARS‐CoV‐2, periodontal pathogens, and host factors: The trinity of oral post‐acute sequelae of COVID‐19. Reviews in Medical Virology. 2024. doi:10.1002/rmv.2543
BibTeX
@article{Schwartz2024,
author = {Schwartz, Joel and Capistrano, Kristelle J and Gluck, Joseph and Hezarkhani, Armita and Naqvi, Afsar R},
title = {SARS‐CoV‐2, periodontal pathogens, and host factors: The trinity of oral post‐acute sequelae of COVID‐19},
journal = {Reviews in Medical Virology},
year = {2024},
doi = {10.1002/rmv.2543}
}
EUVIMED